Skip to main content
News Archive

Biotechs Rule as IPO Market for Venture-Backed Companies is Best Since 2000 – Venture Capital Dispatch – WSJ

By April 3, 2014May 22nd, 2025No Comments

ipo-stock-market-sxc

The IPO market for venture-backed companies is off to a much stronger start than last year, which didn’t really get going until the second quarter.

Castlight Health officials celebrate the company’s IPO at the New York Stock Exchange on March 14. Reuters There were 36 initial public offerings in the first three months of this year compared with eight a year ago, according to data from Thomson Reuters and the National Venture Capital Association. It was the strongest quarter for IPOs since the third quarter of 2000.

{iframe}http://blogs.wsj.com/venturecapital/2014/04/02/biotechs-rule-as-ipo-market-for-venture-backed-companies-is-best-since-2000/{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.